MarketInOut Stock Screener Log In | Sign Up
 

Labiana Health S.A.

BME • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 09/11/2026 17:29
Labiana Health S.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBME
Market Capitalization52.63 mln

EPS

0.36
Marginal

P / E

17.22
Moderately valued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.28
Borderline

Relative Strength

55 / 100
Slightly ahead

Debt / Equity

7.21
Extremely leveraged

Business Description

Founded in 1958 and headquartered near Madrid, Labiana Health S.A. is a Spanish company that produces and sells a broad range of medicines for both animals and people across Europe, North America, and beyond. Its product portfolio covers treatments such as antibiotics, anti-inflammatories, antiparasitics, hormones, and nutritional supplements, along with specialist formats including vaccines and freeze-dried drugs. The company also works with external partners to develop products and manage manufacturing on their behalf.

Key Fundamentals

EPS0.36
P/E17.22
ROE64.90
RPS10.87
ROIC20.43
ROA4.70
Interest Cover1.24
EBITDA, mln10.90
EV / EBITDA7.62
EV / EBIT11.69
Revenue, mln75.18
EV / Revenue1.10

Financial Strength

Altman Z-Score2.56
Piotroski F-Score 6 / 9
Beneish M-Score-2.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 62 / 100   
1 Month -1.59% 54 / 100   
2 Months -9.49% 20 / 100   
6 Months 26.53% 83 / 100   
1 Year 58.97% 87 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us